BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

523 related articles for article (PubMed ID: 25056570)

  • 1. Is the presence of varicocele associated with static and dynamic components of benign prostatic hyperplasia/lower urinary tract symptoms in elderly men?
    Otunctemur A; Ozbek E; Besiroglu H; Dursun M; Sahin S; Koklu I; Erkoc M; Danis E; Bozkurt M; Gurbuz A
    Int J Urol; 2014 Dec; 21(12):1268-72. PubMed ID: 25056570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Prevalence and Association of Varicoceles on Male Patients With Benign Prostatic Hyperplasia/Lower Urinary Tract Symptoms.
    Han H; Yu ZX; Gong LH; Lu RG; Li MQ; Fan CZ; Xie DW; Zhou XG; Zhang XD; Tian L
    Urology; 2016 Apr; 90():97-100. PubMed ID: 26772641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostatic arterial embolization for the treatment of lower urinary tract symptoms as a result of large benign prostatic hyperplasia: A prospective single-center investigation.
    Wang M; Guo L; Duan F; Yuan K; Zhang G; Li K; Yan J; Wang Y; Kang H; Wang Z
    Int J Urol; 2015 Aug; 22(8):766-72. PubMed ID: 25950927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Association of lower urinary tract symptoms and testosterone deficiency in men with type 2 diabetes].
    Kogan MI; Belousov II; Ibishev HS; Cherniy AA; Khripun IA; Vorobyev SV; Sizjakin DV
    Urologiia; 2016 Dec; (6):22-26. PubMed ID: 28248039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective evaluation of the association between varicocele and benign prostatic hyperplasia in men over 40 years of age.
    Gaona J; González F; Sánchez D; González C; Rueda R; Ortiz J; Romero D; Robles P; Osma A; Martínez D; Díaz H; Monterroza F; Zuluaga M; Vanegas M; Rueda E
    Andrologia; 2021 May; 53(4):e13933. PubMed ID: 33586806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination of intravesical prostatic protrusion and resistive index is useful to predict bladder outlet obstruction in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia.
    Suzuki T; Otsuka A; Ozono S
    Int J Urol; 2016 Nov; 23(11):929-933. PubMed ID: 27545297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence and risk of treatment for benign prostatic hyperplasia in Japanese men: a 15-year longitudinal community-based study.
    Fukuta F; Masumori N; Mori M; Tsukamoto T
    Int J Urol; 2013 Jan; 20(1):100-6. PubMed ID: 23106204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors for lower urinary tract symptoms suggestive of benign prostatic hyperplasia in a community based population of healthy aging men: the Krimpen Study.
    Kok ET; Schouten BW; Bohnen AM; Groeneveld FP; Thomas S; Bosch JL
    J Urol; 2009 Feb; 181(2):710-6. PubMed ID: 19091352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Editorial Comment from Dr Zampieri to Is the presence of varicocele associated with static and dynamic components of benign prostatic hyperplasia/lower urinary tract symptoms in elderly men?
    Zampieri N
    Int J Urol; 2014 Dec; 21(12):1272-3. PubMed ID: 25115742
    [No Abstract]   [Full Text] [Related]  

  • 10. Editorial Comment from Dr Li to Is the presence of varicocele associated with static and dynamic components of benign prostatic hyperplasia/lower urinary tract symptoms in elderly men?
    Li F
    Int J Urol; 2014 Dec; 21(12):1272. PubMed ID: 25115707
    [No Abstract]   [Full Text] [Related]  

  • 11. Chronic Prostate Inflammation is Associated with Severity and Progression of Benign Prostatic Hyperplasia, Lower Urinary Tract Symptoms and Risk of Acute Urinary Retention.
    Nickel JC; Roehrborn CG; Castro-Santamaria R; Freedland SJ; Moreira DM
    J Urol; 2016 Nov; 196(5):1493-1498. PubMed ID: 27378134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Six-year follow up of silodosin monotherapy for the treatment of lower urinary tract symptoms suggestive of benign prostatic hyperplasia: What are the factors for continuation or withdrawal?
    Yamanishi T; Kaga K; Fuse M; Shibata C; Kamai T; Uchiyama T
    Int J Urol; 2015 Dec; 22(12):1143-8. PubMed ID: 26310102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic syndrome associated with reduced lower urinary tract symptoms in middle-aged men receiving health checkup.
    Yang TK; Hsieh JT; Chen SC; Chang HC; Yang HJ; Huang KH
    Urology; 2012 Nov; 80(5):1093-7. PubMed ID: 23107400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Correlation Between Prostate Volume in Patients with Benign Prostatic Hyperplasia in Relation to Erectile Dysfunction.
    Kardasevic A; Milicevic S
    Med Arch; 2016 Dec; 70(6):449-452. PubMed ID: 28210019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic syndrome and lower urinary tract symptoms in patients with benign prostatic enlargement: a possible link to storage symptoms.
    De Nunzio C; Cindolo L; Gacci M; Pellegrini F; Carini M; Lombardo R; Franco G; Tubaro A
    Urology; 2014 Nov; 84(5):1181-7. PubMed ID: 25443931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Free prostate-specific antigen is a better tool than total prostate-specific antigen at predicting prostate volume in patients with lower urinary tract symptoms.
    Kayikci A; Cam K; Kacagan C; Tekin A; Ankarali H
    Urology; 2012 Nov; 80(5):1088-92. PubMed ID: 23107399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Direct effects of tadalafil on lower urinary tract symptoms versus indirect effects mediated through erectile dysfunction symptom improvement: integrated data analyses from 4 placebo controlled clinical studies.
    Brock GB; McVary KT; Roehrborn CG; Watts S; Ni X; Viktrup L; Wong DG; Donatucci C
    J Urol; 2014 Feb; 191(2):405-11. PubMed ID: 24096120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Benign Prostatic Hyperplasia: Long-term follow-up of prostate volume reduction after sclerotherapy of the internal spermatic veins.
    Gat Y; Goren M
    Andrologia; 2018 Mar; 50(2):. PubMed ID: 28948696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patient-reported outcomes in men with lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH) treated with intraprostatic OnabotulinumtoxinA: 3-month results of a prospective single-armed cohort study.
    Sacco E; Bientinesi R; Marangi F; Totaro A; D'Addessi A; Racioppi M; Pinto F; Vittori M; Bassi P
    BJU Int; 2012 Dec; 110(11 Pt C):E837-44. PubMed ID: 22712582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new experimental rat model of erectile dysfunction and lower urinary tract symptoms associated with benign prostatic hyperplasia: the testosterone-supplemented spontaneously hypertensive rat.
    Oudot A; Oger S; Behr-Roussel D; Caisey S; Bernabé J; Alexandre L; Giuliano F
    BJU Int; 2012 Nov; 110(9):1352-8. PubMed ID: 22448674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.